potassium phenylbenzimidazole sulfonate은 임신 중 안전한가요?
Potassium phenylbenzimidazole sulfonate (the water‑soluble salt of phenylbenzimidazole sulfonic acid, INCI often reported as Phenylbenzimidazole Sulfonic Acid/its salts) is a UVB filter with no harmonised reproductive classification and no convincing animal or human reproductive/toxic endocrine data in regulatory reviews; CIR/SCCS assessments do not identify reproductive hazard. Dermal absorption is low but measurable for this class of water‑soluble UV filters, so exposure in pregnancy is low but not zero (SCCS/CosIng/PubChem summaries).
Related ingredients
Frequently asked questions
- potassium phenylbenzimidazole sulfonate은 임신 중 안전한가요?
- Potassium phenylbenzimidazole sulfonate (the water‑soluble salt of phenylbenzimidazole sulfonic acid, INCI often reported as Phenylbenzimidazole Sulfonic Acid/its salts) is a UVB filter with no harmonised reproductive classification and no convincing animal or human reproductive/toxic endocrine data in regulatory reviews; CIR/SCCS assessments do not identify reproductive hazard. Dermal absorption is low but measurable for this class of water‑soluble UV filters, so exposure in pregnancy is low but not zero (SCCS/CosIng/PubChem summaries).
- potassium phenylbenzimidazole sulfonate은 모유 수유 중 안전한가요?
- Same rationale as for pregnancy: no regulatory harmonised reproductive or lactation hazard identified and no mechanistic evidence for transfer into milk in available safety assessments; dermal exposure is low but measurable, so postpartum topical use implies low maternal systemic exposure and therefore low likelihood of meaningful transfer into breast milk (SCCS/CosIng/PubChem).
- potassium phenylbenzimidazole sulfonate은 아기 피부에 안전한가요?
- No infant‑specific reproductive or developmental hazards reported; however, due to immature infant barrier and higher surface‑area‑to‑body‑weight, measurable dermal absorption of this water‑soluble UV filter warrants increasing exposure score for 0–3 year skin to moderate. Regulatory safety reviews (SCCS/CosIng) do not flag developmental or endocrine concerns but note exposure considerations for application to young children.
- VeriMom은 potassium phenylbenzimidazole sulfonate을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 potassium phenylbenzimidazole sulfonate을 93/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 potassium phenylbenzimidazole sulfonate 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.